tirzepatide pediatrics New Meds and Tech: Mounjaro (tirzepatide) approved in Medscape - The SURPASS-PEDS trial

If you find that a certain dose is causing persistent issues, your provider can help you navigate a slower titration schedule

These side effects last a short period of time, usually less than 1-2 weeks, after which time they resolve altogether

April 17, 2025

Intermediate Protocol: Months 3 Through 6 After the initial 12-week introduction phase, you enter the optimization period

The most recent update serves as a thorough guide to navigating the shortage, offering solutions to a range of dilemmas that could arise when treating a person who may benefit from a GLP-1 RA

It is not for people with type 1 diabetes or diabetic ketoacidosis